Redeye updates its estimates and valuation following Vitec releasing its Q1 2024 report. Sales came in slightly softer than we had pencilled in, while margins roughly aligned with our expectations. Our view of Vitec’s long-term equity story remains unchanged and we make minor revisions to our estimates and valuation.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/